Inter Miami CF Renews Longstanding Multilayered Partnership with Baptist Health 

• March 18, 2026

ASCO26: Julia Rotow, MD, Silevertinib in Lung Cancer

Dana-Farber Cancer Institute's Dr. Julia Rotow reported on a study looking at silevertinib, with data showing it may offer a new first-line option for hard-to-treat EGFR non-small cell lung cancer variants, with encouraging brain activity and manageable side effects.

• July 1, 2026

• 1 min

ESMO Breast Cancer 2026 Highlights: TRAK-ER

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the TRAK-ER trial, which were presented at the 2026 ESMO Breast Cancer Congress.

• June 26, 2026

• 1 min

The Power List 2026 is Live

We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality

• July 21, 2026

• 1 min